Sneha Rathi

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Topics

Dna Damage Response

Tyrosine Kinase

Diffusion Weighted

Top Venues

The Journal of pharmacology and experimental therapeutics

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Sonia Jain, Jessica I Griffith, Kendra A Porath, Sneha Rathi, Jiayan Le, Tugce I Pasa, Paul A Decker, Shiv K Gupta, Zeng Hu, Brett L Carlson, Katrina K Bakken, Danielle M Burgenske, Thomas M Feldsien, Didier R Lefebvre, Rachael Ann Vaubel, Jeanette E Eckel-Passow, Edward B Reilly, William F Elmquist, Jann N Sarkaria
Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma Models. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Sneha Rathi, Ann C Mladek, Ju-Hee Oh, Sonja Dragojevic, Danielle M Burgenske, Wenjuan Zhang, Surabhi Talele, Wenqiu Zhang, Katrina K Bakken, Brett L Carlson, Margaret A Connors, Lihong He, Zeng Hu, Jann N Sarkaria, William F Elmquist
Factors influencing the Central Nervous System (CNS) distribution of the ATR inhibitor elimusertib (BAY1895344): Implications for the treatment of CNS tumors . The Journal of pharmacology and experimental therapeutics (2024)
Sneha Rathi, Ju-Hee Oh, Wenjuan Zhang, Ann C Mladek, Darwin A Garcia, Zhiyi Xue, Danielle M Burgenske, Wenqiu Zhang, Jiayan Le, Wei Zhong, Jann N Sarkaria, William F Elmquist
Preclinical Systemic Pharmacokinetics, Dose Proportionality, and Central Nervous System Distribution of the ATM Inhibitor WSD0628, a Novel Radiosensitizer for the Treatment of Brain Tumors. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Sneha Rathi, Ju-Hee Oh, Wenjuan Zhang, Ann C Mladek, Darwin A Garcia, Zhiyi Xue, Danielle M Burgenske, Wenqiu Zhang, Jiayan Le, Wei Zhong, Jann N Sarkaria, William F Elmquist
Preclinical Systemic Pharmacokinetics, Dose Proportionality, and Central Nervous System Distribution of the ATM Inhibitor WSD0628, a Novel Radiosensitizer for the Treatment of Brain Tumors. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Sonia Jain, Jessica I Griffith, Kendra A Porath, Sneha Rathi, Jiayan Le, Tugce I Pasa, Paul A Decker, Shiv K Gupta, Zeng Hu, Brett L Carlson, Katrina K Bakken, Danielle M Burgenske, Thomas M Feldsien, Didier R Lefebvre, Rachael Ann Vaubel, Jeanette E Eckel-Passow, Edward B Reilly, William F Elmquist, Jann N Sarkaria
Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma Models. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Sneha Rathi, Ju-Hee Oh, Wenjuan Zhang, Ann C Mladek, Darwin A Garcia, Zhiyi Xue, Danielle M Burgenske, Wenqiu Zhang, Jiayan Le, Wei Zhong, Jann N Sarkaria, William F Elmquist
Preclinical Systemic Pharmacokinetics, Dose Proportionality, and Central Nervous System Distribution of the ATM Inhibitor WSD0628, a Novel Radiosensitizer for the Treatment of Brain Tumors. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Sonia Jain, Jessica I Griffith, Kendra A Porath, Sneha Rathi, Jiayan Le, Tugce I Pasa, Paul A Decker, Shiv K Gupta, Zeng Hu, Brett L Carlson, Katrina K Bakken, Danielle M Burgenske, Thomas M Feldsien, Didier R Lefebvre, Rachael Ann Vaubel, Jeanette E Eckel-Passow, Edward B Reilly, William F Elmquist, Jann N Sarkaria
Bystander effects, pharmacokinetics, and linker-payload stability of EGFR-targeting antibody-drug conjugates Losatuxizumab vedotin and Depatux-M in glioblastoma models. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Sneha Rathi, Ju-Hee Oh, Wenjuan Zhang, Ann C Mladek, Darwin A Garcia, Zhiyi Xue, Danielle M Burgenske, Wenqiu Zhang, Jiayan Le, Wei Zhong, Jann N Sarkaria, William F Elmquist
Preclinical Systemic Pharmacokinetics, Dose Proportionality, and Central Nervous System Distribution of the ATM Inhibitor WSD0628, a Novel Radiosensitizer for the Treatment of Brain Tumors. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Sneha Rathi, Ju-Hee Oh, Wenjuan Zhang, Ann C Mladek, Darwin A Garcia, Zhiyi Xue, Danielle M Burgenske, Wenqiu Zhang, Jiayan Le, Wei Zhong, Jann N Sarkaria, William F Elmquist
Preclinical systemic pharmacokinetics, dose-proportionality, and CNS distribution of the ATM inhibitor WSD0628, a novel radiosensitizer for the treatment of brain tumors . The Journal of pharmacology and experimental therapeutics (2024)
Sonia Jain, Jessica I Griffith, Kendra A Porath, Sneha Rathi, Jiayan Le, Tugce I Pasa, Paul A Decker, Shiv K Gupta, Zeng Hu, Brett L Carlson, Katrina K Bakken, Danielle M Burgenske, Thomas M Feldsien, Didier R Lefebvre, Rachael Ann Vaubel, Jeanette E Eckel-Passow, Edward B Reilly, William F Elmquist, Jann N Sarkaria
Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma Models. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Sneha Rathi, Ju-Hee Oh, Wenjuan Zhang, Ann C Mladek, Darwin A Garcia, Zhiyi Xue, Danielle M Burgenske, Wenqiu Zhang, Jiayan Le, Wei Zhong, Jann N Sarkaria, William F Elmquist
Preclinical Systemic Pharmacokinetics, Dose Proportionality, and Central Nervous System Distribution of the ATM Inhibitor WSD0628, a Novel Radiosensitizer for the Treatment of Brain Tumors. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Sonia Jain, Jessica I Griffith, Kendra A Porath, Sneha Rathi, Jiayan Le, Tugce I Pasa, Paul A Decker, Shiv K Gupta, Zeng Hu, Brett L Carlson, Katrina K Bakken, Danielle M Burgenske, Thomas M Feldsien, Didier R Lefebvre, Rachael Ann Vaubel, Jeanette E Eckel-Passow, Edward B Reilly, William F Elmquist, Jann N Sarkaria
Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma Models. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Wenqiu Zhang, Ju-Hee Oh, Wenjuan Zhang, Sneha Rathi, Jon D Larson, Robert J Wechsler-Reya, Rachael W Sirianni, William F Elmquist
CNS distribution of panobinostat in preclinical models to guide dosing for pediatric brain tumors . The Journal of pharmacology and experimental therapeutics (2023)
Sneha Rathi, Jessica I Griffith, Wenjuan Zhang, Wenqiu Zhang, Ju-Hee Oh, Surabhi Talele, Jann N Sarkaria, William F Elmquist
The influence of the blood-brain barrier in the treatment of brain tumours. Journal of internal medicine 292 (1) (2022)
Jessica I Griffith, Minjee Kim, Daniel J Bruce, Cristina D Peterson, Kelley F Kitto, Afroz S Mohammad, Sneha Rathi, Carolyn A Fairbanks, George L Wilcox, William F Elmquist
CNS Distribution of an Opioid Agonist Combination with Synergistic Activity. The Journal of pharmacology and experimental therapeutics (2021)
Jessica I Griffith, Sneha Rathi, Wenqiu Zhang, Wenjuan Zhang, Lester R Drewes, Jann N Sarkaria, William F Elmquist
Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors. Pharmaceutics 12 (12) (2020)